{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:18:10Z","timestamp":1783297090608,"version":"3.54.6"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:00:00Z","timestamp":1520467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:00:00Z","timestamp":1520467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis C virus (HCV) genotype and subtype (1a\/1b) identification is needed to tailor anti-HCV therapy. Currently available methods accurately identify the genotype and differentiate subtypes 1a from 1b. However, these assays have not been designed to identify other HCV subtypes, nor to recognize mixed genotype\/subtype infections, emphasizing the need for a high-resolution system based on phylogenetic analysis of reads obtained by deep sequencing of a relevant genome region. The aim of this study was to evaluate the performance of the Sentosa SQ HCV Genotyping Assay, a novel deep sequencing-based assay targeting the HCV nonstructural 5B (NS5B) region, in clinical samples from patients with an indication for anti-HCV therapy. A high concordance rate with Sanger sequencing of the NS5B region, the reference method, was found for genotype 1 to 6 determination, 1a\/1b subtype identification, and genotype 4, 5 and 6 subtyping. Discrepancies were seen essentially for HCV genotype 2 subtyping. Overall, the performance of the deep sequencing-based assay in generating the genotypes\/subtype information needed to tailor anti-HCV treatment was adequate in this study. Further improvements, such as a longer NS5B fragment analyzed and enriching the database of reference prototype strains used for subtype assignment would make it a method of choice for HCV genotyping and subtyping for future clinical practice and research.<\/jats:p>","DOI":"10.1038\/s41598-018-22614-0","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T11:04:36Z","timestamp":1519988676000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A novel standardized deep sequencing-based assay for hepatitis C virus genotype determination"],"prefix":"10.1038","volume":"8","author":[{"given":"Christophe","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Soulier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Demontant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Poiteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Mercier-Darty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Bouvier-Alias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Pawlotsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Chevaliez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,8]]},"reference":[{"key":"22614_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","volume":"2","author":"HCVC Polaris Observatory","year":"2017","unstructured":"Polaris Observatory, H. C. V. C. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2, 161\u2013176, https:\/\/doi.org\/10.1016\/S2468-1253(16)30181-9 (2017).","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"22614_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/hep.26744","volume":"59","author":"DB Smith","year":"2014","unstructured":"Smith, D. B. et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 59, 318\u2013327, https:\/\/doi.org\/10.1002\/hep.26744 (2014).","journal-title":"Hepatology"},{"key":"22614_CR3","first-page":"121A","volume":"66","author":"C Hedskog","year":"2017","unstructured":"Hedskog, C. et al. Identification of novel HCV genotype and subtypes in patients treated with sofosbuvir based regimens. Hepatology 66, 121A (2017).","journal-title":"Hepatology"},{"key":"22614_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/hep.1840210243","volume":"21","author":"P Simmonds","year":"1995","unstructured":"Simmonds, P. Variability of hepatitis C virus. Hepatology 21, 570\u2013583 (1995).","journal-title":"Hepatology"},{"key":"22614_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/M17-1073","volume":"167","author":"PS Belperio","year":"2017","unstructured":"Belperio, P. S., Chartier, M., Ross, D. B., Alaigh, P. & Shulkin, D. Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs. Ann Intern Med 167, 499\u2013504, https:\/\/doi.org\/10.7326\/M17-1073 (2017).","journal-title":"Ann Intern Med"},{"key":"22614_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.7326\/M16-2575","volume":"166","author":"O Falade-Nwulia","year":"2017","unstructured":"Falade-Nwulia, O. et al. Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review. Ann Intern Med 166, 637\u2013648, https:\/\/doi.org\/10.7326\/M16-2575 (2017).","journal-title":"Ann Intern Med"},{"key":"22614_CR7","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver. Electronic address, e. e. e. EASL Recommendations on Treatment of Hepatitis C 2016. J Hepatol 66, 153-194, https:\/\/doi.org\/10.1016\/j.jhep.2016.09.001 (2017).","DOI":"10.1016\/j.jhep.2016.09.001"},{"key":"22614_CR8","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/hep.27950","volume":"62","author":"AIHGH Panel","year":"2015","unstructured":"Panel, A. I. H. G. H. C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 62, 932\u2013954, https:\/\/doi.org\/10.1002\/hep.27950 (2015).","journal-title":"Hepatology"},{"key":"22614_CR9","doi-asserted-by":"publisher","first-page":"e8209","DOI":"10.1371\/journal.pone.0008209","volume":"4","author":"S Chevaliez","year":"2009","unstructured":"Chevaliez, S., Bouvier-Alias, M., Brillet, R. & Pawlotsky, J. M. Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice. PLoS One 4, e8209, https:\/\/doi.org\/10.1371\/journal.pone.0008209 (2009).","journal-title":"PLoS One"},{"key":"22614_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jcv.2017.03.007","volume":"90","author":"MA Mallory","year":"2017","unstructured":"Mallory, M. A. et al. Evaluation of the Abbott RealTime HCV genotype II plus RUO (PLUS) assay with reference to core and NS5B sequencing. J Clin Virol 90, 26\u201331, https:\/\/doi.org\/10.1016\/j.jcv.2017.03.007 (2017).","journal-title":"J Clin Virol"},{"key":"22614_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1128\/JCM.01960-16","volume":"55","author":"L Nieto-Aponte","year":"2017","unstructured":"Nieto-Aponte, L. et al. Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing. J Clin Microbiol 55, 504\u2013509, https:\/\/doi.org\/10.1128\/JCM.01960-16 (2017).","journal-title":"J Clin Microbiol"},{"key":"22614_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1128\/JCM.02093-14","volume":"53","author":"J Quer","year":"2015","unstructured":"Quer, J. et al. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods. J Clin Microbiol 53, 219\u2013226, https:\/\/doi.org\/10.1128\/JCM.02093-14 (2015).","journal-title":"J Clin Microbiol"},{"key":"22614_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.12.016","author":"JA Del Campo","year":"2017","unstructured":"Del Campo, J. A. et al. HCV deep-sequencing for sub-genotypes identification of mixed infections: a real life experience. Int J Infect Dis. https:\/\/doi.org\/10.1016\/j.ijid.2017.12.016 (2017).","journal-title":"Int J Infect Dis"},{"key":"22614_CR14","doi-asserted-by":"publisher","first-page":"775 e771","DOI":"10.1016\/j.cmi.2017.02.007","volume":"23","author":"F Rodriguez-Frias","year":"2017","unstructured":"Rodriguez-Frias, F. et al. High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtyping. Clin Microbiol Infect 23, 775 e771\u2013775 e776, https:\/\/doi.org\/10.1016\/j.cmi.2017.02.007 (2017).","journal-title":"Clin Microbiol Infect"},{"key":"22614_CR15","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1128\/JCM.01300-08","volume":"47","author":"S Chevaliez","year":"2009","unstructured":"Chevaliez, S., Bouvier-Alias, M. & Pawlotsky, J. M. Performance of the Abbott real-time PCR assay using m2000sp and m2000rt for hepatitis C virus RNA quantification. J Clin Microbiol 47, 1726\u20131732, https:\/\/doi.org\/10.1128\/JCM.01300-08 (2009).","journal-title":"J Clin Microbiol"},{"key":"22614_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0166-0934(03)00070-3","volume":"109","author":"K Sandres-Saune","year":"2003","unstructured":"Sandres-Saune, K. et al. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 109, 187\u2013193 (2003).","journal-title":"J Virol Methods"},{"issue":"Pt 5","key":"22614_CR17","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1099\/0022-1317-75-5-1053","volume":"75","author":"P Simmonds","year":"1994","unstructured":"Simmonds, P. et al. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol 75(Pt 5), 1053\u20131061, https:\/\/doi.org\/10.1099\/0022-1317-75-5-1053 (1994).","journal-title":"J Gen Virol"},{"key":"22614_CR18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1099\/0022-1317-82-5-1001","volume":"82","author":"Y Morice","year":"2001","unstructured":"Morice, Y. et al. Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J Gen Virol 82, 1001\u20131012, https:\/\/doi.org\/10.1099\/0022-1317-82-5-1001 (2001).","journal-title":"J Gen Virol"},{"key":"22614_CR19","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1053\/j.gastro.2006.07.022","volume":"131","author":"JP Bronowicki","year":"2006","unstructured":"Bronowicki, J. P. et al. Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin. Gastroenterology 131, 1040\u20131048, https:\/\/doi.org\/10.1053\/j.gastro.2006.07.022 (2006).","journal-title":"Gastroenterology"},{"key":"22614_CR20","unstructured":"Felsenstein, J. PHYLIP: phylogeny inference package, version 3.5c (computer program). Distributed by the author. Department of Genetics, University of Washington, Seattle (1993)."},{"key":"22614_CR21","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","volume":"22","author":"JD Thompson","year":"1994","unstructured":"Thompson, J. D., Higgins, D. G. & Gibson, T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673\u20134680 (1994).","journal-title":"Nucleic Acids Res"},{"key":"22614_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00239-001-0018-9","volume":"54","author":"M Salemi","year":"2002","unstructured":"Salemi, M. & Vandamme, A. M. Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences. J Mol Evol 54, 62\u201370 (2002).","journal-title":"J Mol Evol"},{"key":"22614_CR23","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrg2583","volume":"10","author":"OG Pybus","year":"2009","unstructured":"Pybus, O. G. & Rambaut, A. Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet 10, 540\u2013550, https:\/\/doi.org\/10.1038\/nrg2583 (2009).","journal-title":"Nat Rev Genet"},{"key":"22614_CR24","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1128\/JVI.76.8.4034-4043.2002","volume":"76","author":"O Kalinina","year":"2002","unstructured":"Kalinina, O., Norder, H., Mukomolov, S. & Magnius, L. O. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 76, 4034\u20134043 (2002).","journal-title":"J Virol"},{"key":"22614_CR25","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1128\/JCM.02209-14","volume":"52","author":"JR Guelfo","year":"2014","unstructured":"Guelfo, J. R. et al. Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment. J Clin Microbiol 52, 4027\u20134029, https:\/\/doi.org\/10.1128\/JCM.02209-14 (2014).","journal-title":"J Clin Microbiol"},{"key":"22614_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jviromet.2017.10.005","volume":"251","author":"G Dirani","year":"2017","unstructured":"Dirani, G. et al. A novel next generation sequencing assay as an alternative to currently available methods for hepatitis C virus genotyping. J Virol Methods 251, 88\u201391, https:\/\/doi.org\/10.1016\/j.jviromet.2017.10.005 (2017).","journal-title":"J Virol Methods"},{"key":"22614_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jhep.2017.03.014","volume":"67","author":"TM Welzel","year":"2017","unstructured":"Welzel, T. M. et al. Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses. J Hepatol 67, 224\u2013236, https:\/\/doi.org\/10.1016\/j.jhep.2017.03.014 (2017).","journal-title":"J Hepatol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22614-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22614-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22614-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:15:28Z","timestamp":1671592528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22614-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,8]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["22614"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-22614-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,8]]},"assertion":[{"value":"1 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JMP and SC acted as advisors for Abbott. Other authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4180"}}